Eagle Pharmaceuticals, Inc. Total Long-Term Debt
Eagle Pharmaceuticals, Inc. had Total Long-Term Debt of $71.25 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2023-08-09
- 2023-06-30: Long-term Debt $71.25M.
- 2023-03-31: Long-term Debt $77.50M.
- 2022-12-31: Long-term Debt $63.75M.
- 2022-09-30: Long-term Debt $59.32M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2023-06-30 | $71.25M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $77.50M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $63.75M 10-K · filed 2023-03-23 | |
| 2022-09-30 | $59.32M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $48.12M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $24.00M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $26.00M 10-K · filed 2022-03-08 | |
| 2021-09-30 | $28.00M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $30.00M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $32.00M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $34.00M 10-K · filed 2021-03-05 | |
| 2020-09-30 | $36.00M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $37.00M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $148.00M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $34.00M 10-K · filed 2021-03-05 | $39.00M 10-K · filed 2020-03-02 |
| 2019-09-30 | $40.00M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $41.25M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $42.50M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $45.00M 10-K · filed 2019-02-28 | |
| 2018-09-30 | $45.00M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $47.50M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $48.75M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $48.75M 10-K · filed 2018-02-26 |